Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000608082 | SCV000729308 | likely benign | not specified | 2017-08-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000860862 | SCV001001031 | likely benign | Developmental and epileptic encephalopathy, 36 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000860862 | SCV002798012 | likely benign | Developmental and epileptic encephalopathy, 36 | 2021-10-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001702814 | SCV004167465 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | ALG13: BP4, BP7 |
Breakthrough Genomics, |
RCV001702814 | SCV005206718 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001702814 | SCV001929980 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702814 | SCV001967407 | likely benign | not provided | no assertion criteria provided | clinical testing |